M.‐C. Mathieu

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

Maria Vittoria Dieci, Carmen Criscitiello, Aïcha Goubar et al. · Annals of Oncology · 2014 · 465 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

Maria Vittoria Dieci, M.‐C. Mathieu, Valentina Guarneri et al. · Annals of Oncology · 2015 · 314 citations · Full text

Medicine, Immunology, Oncology +16

COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial

Cédric Annweiler, Mélinda Beaudenon, Jennifer Gautier et al. · Trials · 2020 · 91 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases

Jocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni et al. · BMC Cancer · 2013 · 59 citations · Full text

Medicine, Oncology, Pathology +14

Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis

J.P. Travagli, David Atallah, M.‐C. Mathieu et al. · European Journal of Surgical Oncology · 2003 · 48 citations

Medicine, Oncology, Surgery +17